Press Releases ViroGates A/S

Equities

VIRO

DK0061030574

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2024-07-15 EDT			5-day change	1st Jan Change
6.45 ^DKK	-0.77%		-3.01%	+7.14%

05-02	ViroGates A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-15	Virogates A/S Announces the Outcome of Its Q-Submission Filing for Sobi®? Turbi Latex with the Us Food and Drug Administration	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ViroGates A/S : Interim Report, Q1 2024	05-02	PU
ViroGates announces its Interim Report for Q1, 2024: Quarterly revenue up 14% compared to Q1, 2023	05-02	AQ
Resolutions from the Annual General Meeting of ViroGates A/S	04-25	AQ
ViroGates announces the outcome of its Q-Submission filing for suPARnostic® TurbiLatex with the US FDA and the overall timeline for filing a submission of a 510k/“De Novo” application with the FDA	04-15	AQ
ViroGates gives notice to convene the Annual General Meeting on 25 April 2024	04-10	AQ
ViroGates announces its Annual Report 2023: Revenue was affected by the loss of COVID-19 customers and a difficult transition into general triage	03-21	AQ
Subscription of shares by majority shareholder in relation to the recently completed rights emission in ViroGates A/S	12-21	AQ
ViroGates notification of transactions by persons discharging managerial responsibilities according to MAR art. 19	12-21	AQ
ViroGates publishes its financial calendar for 2024	12-21	AQ
ViroGates announces financial guidance for 2024	12-21	AQ
ViroGates' capital raise of DKK 13.9 million and issue of 3,097,047 new shares have been registered	12-19	AQ
ViroGates announces the outcome of its rights issue	12-15	AQ
ViroGates A/S : Most interesting suPAR studies of 2023	12-08	PU
ViroGates notification of transactions by persons discharging managerial responsibilities according to MAR art. 19	12-07	AQ
ViroGates A/S : Clinical role of suPAR in the prognosis of patients in the emergency setting and its influence on risk stratification	12-06	PU
The subscription period in ViroGates’ rights issue begins today	11-30	AQ
Resolutions from the Extraordinary General Meeting of ViroGates A/S	11-24	AQ
ViroGates A/S : Social isolation in mid-adulthood is associated with elevated suPAR	11-23	PU
ViroGates gives notice to convene an Extraordinary General Meeting on 24 November 2023	11-09	AQ
ViroGates announces an offering of new shares with pre-emptive rights for existing shareholders	11-09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ViroGates A/S

Equities

VIRO

DK0061030574

Press Releases

Filters